ArkeaBio Appoints Dr. Zach Serber as Chief Technology Officer to Accelerate Development of Methane-Reducing Livestock Vaccine - CleanTechnica

ArkeaBio, a global agricultural bioscience company developing the first vaccine to reduce methane emissions from cattle, has appointed Dr. Zach Serber as its Chief Technology Officer. Dr. Serber brings over 20 years of experience in synthetic biology and industrial biotechnology, having previously held leadership roles at Zymergen, Amyris, and Evozyne. His expertise includes integrating robotics and machine learning into industrial fermentation and advancing bio-based solutions for health and sustainability. At ArkeaBio, he will lead scientific strategy to accelerate product validation and commercial deployment of the methane-reducing vaccine. The vaccine aims to provide a practical, cost-effective method for farmers to reduce methane emissions—a greenhouse gas over 80 times more potent than CO₂ in the short term—while enhancing livestock productivity. ArkeaBio plans to transition from current animal studies to full field trials by 2026, with commercial launch shortly thereafter, aligning with 2030 emissions targets. The company’s approach targets a $4 billion global market for